The pharmaceutical manufacturing landscape for oral mesalazine has undergone substantial transformation, driven by technological advancements, regulatory evolution, and the imperative for supply chain resilience. As a mature active pharmaceutical ingredient with established synthetic routes, mesalazine production might appear straightforward, yet contemporary manufacturing demands extend far...

The Oral Mesalazine Market plays an important role in the treatment of inflammatory bowel diseases (IBD), particularly ulcerative colitis and mild-to-moderate Crohn’s disease. Oral mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is widely prescribed to reduce intestinal inflammation, induce remission, and maintain long-term disease control. As the global burden of...